What’s Vulnerable › Vulnerabilities

CVE-2016-8355

• Severity: critical (CVSS 9.9 v3.0)
• Exploited in the wild: not listed in CISA KEV
• EPSS: 1.5% probability of exploitation in the next 30 days
• Public exploit or detection template: none known
• Published: 2017-02-13 · updated 2026-06-17
• Weakness: CWE-306

Description

An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.

Affected products

• Smiths-Medical CADD-Solis Medication Safety Software through 3.1: 1.0, 2.0, 3.0, 3.1

References

• http://www.securityfocus.com/bid/94630
• https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01
• http://www.securityfocus.com/bid/94630
• https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01

Get alerted when CVE-2016-8355 or the next vulnerability affects your stack